Go Pro

Corient Private Wealth LP Buys Shares of 72,056 Surgery Partners, Inc. $SGRY

Surgery Partners logo with Healthcare background
Image from MarketBeat Media, LLC.

Corient Private Wealth LP purchased a new position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 72,056 shares of the company's stock, valued at approximately $1,211,000. Corient Private Wealth LP owned about 0.06% of Surgery Partners as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. State of Wisconsin Investment Board boosted its holdings in Surgery Partners by 0.4% during the fourth quarter. State of Wisconsin Investment Board now owns 151,504 shares of the company's stock worth $2,341,000 after buying an additional 668 shares during the last quarter. ProShare Advisors LLC boosted its stake in Surgery Partners by 6.9% during the 4th quarter. ProShare Advisors LLC now owns 14,135 shares of the company's stock worth $218,000 after acquiring an additional 909 shares during the last quarter. California State Teachers Retirement System grew its holdings in Surgery Partners by 1.6% during the second quarter. California State Teachers Retirement System now owns 65,091 shares of the company's stock valued at $1,447,000 after purchasing an additional 1,021 shares during the period. Sanctuary Advisors LLC increased its stake in Surgery Partners by 4.5% in the fourth quarter. Sanctuary Advisors LLC now owns 28,488 shares of the company's stock valued at $440,000 after purchasing an additional 1,218 shares in the last quarter. Finally, Empowered Funds LLC increased its stake in Surgery Partners by 11.0% in the first quarter. Empowered Funds LLC now owns 12,853 shares of the company's stock valued at $305,000 after purchasing an additional 1,278 shares in the last quarter.

Insider Activity at Surgery Partners

In other Surgery Partners news, Director Teresa DeLuca purchased 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 18th. The shares were acquired at an average cost of $14.35 per share, for a total transaction of $143,500.00. Following the completion of the purchase, the director owned 66,843 shares of the company's stock, valued at approximately $959,197.05. The trade was a 17.59% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on SGRY. Benchmark reissued a "buy" rating on shares of Surgery Partners in a report on Tuesday, August 11th. Zacks Research cut Surgery Partners from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 10th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $18.00 price target on shares of Surgery Partners in a research report on Tuesday, August 11th. TD Cowen boosted their price objective on Surgery Partners from $17.00 to $19.00 and gave the company a "buy" rating in a research report on Tuesday, August 11th. Finally, Weiss Ratings reissued a "sell (e+)" rating on shares of Surgery Partners in a research note on Friday, August 21st. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $19.45.

Check Out Our Latest Research Report on Surgery Partners

Surgery Partners Trading Up 0.6%

Surgery Partners stock opened at $14.26 on Friday. The stock has a 50-day simple moving average of $15.40 and a 200 day simple moving average of $14.37. The stock has a market capitalization of $1.87 billion, a P/E ratio of -20.37, a PEG ratio of 4.37 and a beta of 1.92. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95. Surgery Partners, Inc. has a 52 week low of $11.41 and a 52 week high of $23.44.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings data on Monday, August 10th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.06 by $0.04. Surgery Partners had a negative net margin of 2.63% and a positive return on equity of 0.88%. The firm had revenue of $848.90 million for the quarter, compared to the consensus estimate of $830.03 million. During the same period in the previous year, the company earned $0.17 earnings per share. The company's quarterly revenue was up 2.7% on a year-over-year basis. Analysts expect that Surgery Partners, Inc. will post 0.22 earnings per share for the current year.

Surgery Partners Profile

(Free Report)

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.

Featured Articles

Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRY - Free Report).

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Surgery Partners Right Now?

Before you consider Surgery Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.

While Surgery Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines